著者: MahrleG, SchulzeH J, FärberL, WeidingerG, SteiglederG K

原題: Low-dose short-term cyclosporine versus etretinate in psoriasis: improvement of skin, nail, and joint involvement.

著者: El-MarakbyMai G, SolaymanMohamed H, SabriNagwa A

原題: Evaluation of the Safety Profile of Direct-Acting Antivirals on Patients with Hepatitis C Virus: A Pharmacovigilance Study.

著者: ParkashArit, MerchantAyesha Altaf, AhmedSyed Habib, HussainWajid, HayatMuhammad, MemonNadeem Ahmed

原題: Effectiveness And Safety Of Direct Acting Antiviral Agents In Thalassaemic Patients With Chronic Hepatitis C.

著者: YounasSonia, MukhtarHamid, GoharUmar Farooq, AlsrhaniAbdullah, AlzahraniBadr, JunaidKashaf, QamarMuhammad Usman, EjazHasan

原題: Diagnostic approach to elucidate the efficacy and side effects of direct-acting antivirals in HCV infected patients.

著者: El KassasMohamed, AbdeenNermeen, OmranDalia, AlboraieMohamed, SalaheldinMohamed, EltabbakhMohamed, FarghalyRasha, EmadeldeenMohammed, AfifyShimaa, SweedyAhmad, GhalwashAhmed, AbbassAmr, EzzatSameera, TahoonMarwa, ELshazlyHelmy M, HamdyHassan, OmarHeba

原題: Safety and efficacy of sofosbuvir/ledipasvir and sofosbuvir/daclatasvir in the treatment of hepatitis C in patients with decompensated cirrhosis.

著者: YahyaGalal, Hashem MohamedNashwa, PijuanJordi, SeleemNoura M, MosbahRasha, HessSteffen, AbdelmoatyAhmed A, AlmeerRafa, Abdel-DaimMohamed M, Shulaywih AlshamanHamoud, JuraibyIbrahim, MetwallyKamel, StorchovaZuzana

原題: Profiling the physiological pitfalls of anti-hepatitis C direct-acting agents in budding yeast.

著者: Abo-AmerYousry Esam-Eldin, BadawiRehab, El-AbgeegyMohamed, ElserganyHeba Fadl, MohamedAhmed Abdelhaleem, MostafaSahar Mohamed, AlegailyHatem Samir, SolimanShaimaa, ElnawasanySally, Abd-ElsalamSherief

原題: Quadruple Therapy Offers High SVR Rates in Patients with HCV Genotype 4 with Previous Treatment Failure.

著者: SonderupM W, GogelaN, NordienR, SmutsH, KorsmanS, HardieD, SpearmanC W

原題: Direct-acting antiviral therapy for hepatitis C: The initial experience of the University of Cape Town/Groote Schuur Hospital Liver Clinic, South Africa.

著者: NaveedMariam, AliAmjad, SheikhNadeem, RafiqueShazia, IdreesMuhammad

原題: Expression of TRIM22 mRNA in chronic hepatitis C patients treated with direct-acting antiviral drugs.

著者: De PaceVanessa, MorelliMaria Cristina, RavaioliMatteo, MaggiFabrizio, GalliSilvia, VeroVittoria, ReMaria Carla, CesconMatteo, PistelloMauro

原題: Efficacy, Safety, and Predictors of Direct-acting antivirals in Hepatitis C Virus Patients with Heterogeneous Liver Diseases.

著者: LobatoCirley Maria de Oliveira, CodesLiana, SilvaGiovanni Faria, SouzaAécio Flávio Meirelles, CoelhoHenrique Sérgio Moraes, PedrosoMaria Lucia Alves, PariseEdison Roberto, LimaLeila Maria Soares Tojal de Barros, BorbaLuiz Augusto, EvangelistaAndreia Silva, RezendeRosamar Eulira Fontes, CheinquerHugo, KuniyoshiAline Satie Oba, AiresRodrigo Sebba, QuintelaEloiza Helena Dias, MendesLiliana Sampaio Costa, NascimentoFábio Carneiro Vosqui, Medeiros FilhoJosé Eymard Moraes de, FerrazMaria Lúcia Cardoso Gomes, AbdalaEdson, BittencourtPaulo Lisboa,

原題: Direct antiviral therapy for treatment of hepatitis C: A real-world study from Brazil.

著者: AguiarBruna Forte, CamposGuilherme Rodrigues Fernandes, RodriguesJoão Paulo Vilela, MarquesNayara Nathie, MolinaBárbara Floriano, BittarCintia, SouzaFernanda Fernandes, MartinelliAna de Lourdes Candolo, RahalPaula, PereiraLeonardo Régis Leira

原題: Baseline resistance associated substitutions in HCV genotype 1 infected cohort treated with Simeprevir, Daclatasvir and Sofosbuvir in Brazil.

著者: ZanagaL P, SantosA G, AtaídeE C, BoinI F S F, StucchiR S B

原題: Recurrent hepatitis C treatment with direct acting antivirals - a real life study at a Brazilian liver transplant center.

著者: HanQunying, FanXiude, WangXiaoyun, WangYe, DengHuan, ZhangXiaoge, ZhangKun, LiNa, LiuZhengwen

原題: High sustained virologic response rates of sofosbuvir-based regimens in Chinese patients with HCV genotype 3a infection in a real-world setting.

著者: LionettiRaffaella, PiccoloPaola, LenciIlaria, SicilianoMassimo, Visco-ComandiniUbaldo, De SantisAdriano, PompiliMaurizio, MilanaMartina, TaibiChiara, Dell'IsolaSerena, MontalbanoMarzia, MastroianniClaudio, BeginiPaola, GarbugliaAnna Rosa, AngelicoMario, D'OffiziGianpiero

原題: Daclatasvir, sofosbuvir with or without ribavirin for 24 weeks in hepatitis C genotype 3 cirrhosis: A real-life study.

著者: CalvarusoVincenza, MazzarelliChiara, MilazzoLaura, BadiaLorenzo, PasuloLuisa, GuaraldiGiovanni, LionettiRaffaella, VillaErica, BorghiVanni, CarraiPaola, AlbertiAlfredo, BiolatoMarco, PiaiGuido, PersicoMarcello, SantantonioTeresa, FelderMartina, AngelicoMario, MontalbanoMarzia, MancusiRossella Letizia, GriecoAntonio, AngeliElena, D'OffiziGianpiero, FagiuoliStefano, BelliLuca, VerucchiGabriella, PuotiMassimo, CraxìAntonio

原題: Daclatasvir-based regimens in HCV cirrhosis: experience from the Italian early access program.

著者: BourlièreMarc, PietriOlivia

原題: Hepatitis C virus therapy: No one will be left behind.

著者: AhmedEman I, Abdel WahedWafaa Y, HassanEssam A, AhmedTarek I

原題: Study of Adverse Drug Effects of Direct-Acting Antivirals for Chronic HCV Infection at Fayoum Governorate, Egypt - A Pharmacovigilance Study.

著者: SundbergIsak, LannergårdAnders, RamklintMia, CunninghamJanet L

原題: Direct-acting antiviral treatment in real world patients with hepatitis C not associated with psychiatric side effects: a prospective observational study.

著者: OhashiKazuki, IshikawaToru, SuzukiMitsuyuki, AbeHiroko, KoyamaFujiko, NakanoTomomi, UekiAya, NoguchiHirohito, HasegawaErina, HirosawaShiori, KobayashiMiki, HirosawaHiroshi, SatoKaede, FukazawaTakako, MaruyamaYuka, YoshidaToshiaki

原題: Health-related quality of life on the clinical course of patients with chronic hepatitis C receiving daclatasvir/asunaprevir therapy: A prospective observational study comparing younger (<70) and elderly (≥70) patients.

著者: El-KhayatH, FouadY, MohamedH I, El-AminH, KamalE M, MaherM, RiskA

原題: Sofosbuvir plus daclatasvir with or without ribavirin in 551 patients with hepatitis C-related cirrhosis, genotype 4.

著者: ShimadaMichiko, NakamuraNorio, EndoTetsu, YamabeHideaki, NakamuraMasayuki, MurakamiReiichi, NaritaIkuyo, TomitaHirofumi

原題: Daclatasvir/asunaprevir based direct-acting antiviral therapy ameliorate hepatitis C virus-associated cryoglobulinemic membranoproliferative glomerulonephritis: a case report.